Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InductOs (rhBMP-2; dibotermin alfa) vs autologous bone grafting for nonunion at tibial bone transport docking site
2012-005664-10Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of dibotermin alfa in Tibial non-union (2 arms), sponsored by UZ Leuven. Primary endpoint: Healing of tibial nonunion at docking site. Started Aug 2015; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
Tibial non-union
Beyond the preview
Go deeper on 2012-005664-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005664-10.